Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$36.28 - $75.29 $841,696 - $1.75 Million
-23,200 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$69.73 - $142.9 $355,623 - $728,790
5,100 Added 28.18%
23,200 $1.71 Million
Q4 2021

Feb 14, 2022

BUY
$134.56 - $217.97 $2.44 Million - $3.95 Million
18,100 New
18,100 $2.59 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.